📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
8
ERAS Latest News & AI Sentiment Analysis
0 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
Erasca announces $500M common stock offering (ERAS:NASDAQ)
Erasca announced a $500M common stock offering with a $75M greenshoe option, raising capital for R&D and operational needs. This...
Erasca Announces Proposed Public Offering of $500 Million of Common Stock
Erasca (ERAS), a clinical-stage precision oncology company, announced a $500 million public offering of common stock with an additional...
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
Erasca has released updated Phase 1 clinical trial data for ERAS-0015, a pan-RAS molecular glue candidate targeting KRAS-mutant solid...
ERAS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
Erasca (ERAS) faces an August 10, 2026 deadline for investors to join an ongoing securities class action lawsuit, signaling continued...
Erasca (ERAS) Receives Encouraging Expert Feedback on ERAS-0015 Clinical Trials
Erasca (ERAS) has reported favorable expert feedback regarding its ERAS-0015 clinical trial program, generating positive sentiment among...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice